Buy AIMD by Dec 13, 2026.

$AIMD just hit an important inflection point. The big update: Ainos is moving its AI Nose from front-end wafer-fab validation into commercial deployment, and the company says it is now receiving initial orders from a front-end semiconductor customer. That matters because the story is starting to shift from “interesting technology” to “can this actually turn into orders and revenue?” A few things stood out to me: * Front-end wafer-fab validation is now progressing toward commercial adoption * Management is tying …